CMV reactivation initiates long-term expansion and differentiation of the NK cell repertoire.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 04 05 2022
accepted: 04 11 2022
entrez: 19 12 2022
pubmed: 20 12 2022
medline: 21 12 2022
Statut: epublish

Résumé

NK cells play an important role in suppression of viral replication and are critical for effective control of persistent infections such as herpesviruses. Cytomegalovirus infection is associated with expansion of 'adaptive-memory' NK cells with a characteristic CD56dimCD16bright NKG2C+ phenotype but the mechanisms by which this population is maintained remain uncertain. We studied NK cell reconstitution in patients undergoing haemopoietic stem cell transplantation and related this to CMV reactivation. NK cells expanded in the early post-transplant period but then remained stable in the absence of viral reactivation. However, CMV reactivation led to a rapid and sustained 10-fold increase in NK cell number. The proportion of NKG2C-expressing cells increases on all NK subsets although the kinetics of expansion peaked at 6 months on immature CD56bright cells whilst continuing to rise on the mature CD56dim pool. Phenotypic maturation was observed by acquisition of CD57 expression. Effective control of viral reactivation was seen when the peripheral NK cell count reached 20,000/ml. These data show that short term CMV reactivation acts to reprogramme hemopoiesis to drive a sustained modulation and expansion of the NK cell pool and reveal further insight into long term regulation of the innate immune repertoire by infectious challenge.

Identifiants

pubmed: 36531994
doi: 10.3389/fimmu.2022.935949
pmc: PMC9753568
doi:

Substances chimiques

NK Cell Lectin-Like Receptor Subfamily C 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

935949

Subventions

Organisme : Medical Research Council
ID : MR/R011230/1
Pays : United Kingdom

Informations de copyright

Copyright © 2022 Hassan, Eldershaw, Stephens, Kinsella, Craddock, Malladi, Zuo and Moss.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Aging (Albany NY). 2019 Jan 27;11(2):724-740
pubmed: 30686790
Blood. 2016 May 19;127(20):2427-38
pubmed: 26884374
Biol Blood Marrow Transplant. 2016 Dec;22(12):2187-2193
pubmed: 27664326
Br J Haematol. 2020 Nov;191(4):612-616
pubmed: 33190255
Blood. 2008 Aug 1;112(3):461-9
pubmed: 18650461
Clin Exp Immunol. 2009 Mar;155(3):423-32
pubmed: 19220832
Leukemia. 2016 Feb;30(2):456-63
pubmed: 26416461
J Immunol. 2014 Feb 15;192(4):1471-9
pubmed: 24442432
Immunity. 2019 Jun 18;50(6):1391-1400.e4
pubmed: 31103380
Blood. 2017 Apr 6;129(14):1940-1946
pubmed: 27903532
Eur J Immunol. 2004 Dec;34(12):3456-64
pubmed: 15517612
Nat Rev Immunol. 2020 Nov;20(11):694-707
pubmed: 32424244
Nature. 1998 Feb 19;391(6669):795-9
pubmed: 9486650
J Allergy Clin Immunol. 2013 Sep;132(3):515-525
pubmed: 23993353
Blood. 2004 Dec 1;104(12):3664-71
pubmed: 15304389
Blood. 2012 Jan 12;119(2):399-410
pubmed: 22096237
Front Immunol. 2019 Apr 03;10:687
pubmed: 31001281
Biol Blood Marrow Transplant. 2015 Mar;21(3):429-39
pubmed: 25579888
J Immunol. 2013 Jun 15;190(12):6269-76
pubmed: 23656738
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16
pubmed: 26211985
Blood. 2011 Aug 4;118(5):1402-12
pubmed: 21540462
Front Immunol. 2018 May 15;9:1050
pubmed: 29868012
Immunity. 2021 Oct 12;54(10):2288-2304.e7
pubmed: 34437840
J Exp Med. 2011 Feb 14;208(2):357-68
pubmed: 21262959
J Exp Med. 2003 Apr 21;197(8):967-76
pubmed: 12695488
Bone Marrow Transplant. 2013 Oct;48(10):1313-6
pubmed: 23562969
Blood. 2013 Apr 4;121(14):2678-88
pubmed: 23325834
Nat Immunol. 2018 May;19(5):453-463
pubmed: 29632329
Clin Immunol. 2009 Nov;133(2):171-8
pubmed: 19481979
JCI Insight. 2019 Jan 24;4(2):
pubmed: 30674718
J Immunol. 2012 Nov 15;189(10):5082-8
pubmed: 23077239
Blood. 2012 Mar 15;119(11):2665-74
pubmed: 22180440
Immunity. 2017 Nov 21;47(5):820-833
pubmed: 29166586
Haematologica. 2008 Dec;93(12):1852-8
pubmed: 18945751
Blood. 2013 Aug 15;122(7):1316-24
pubmed: 23744585
Blood Adv. 2017 Aug 21;1(19):1589-1597
pubmed: 29296800
JCI Insight. 2021 Jun 22;6(12):
pubmed: 34003794
Clin Infect Dis. 2009 Dec 15;49(12):1777-83
pubmed: 19911937
Front Immunol. 2019 Jun 19;10:1415
pubmed: 31316503
Immunity. 2015 Mar 17;42(3):443-56
pubmed: 25786176
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):
pubmed: 35181606
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14725-32
pubmed: 21825173
Sci Immunol. 2018 Nov 2;3(29):
pubmed: 30389798
Front Immunol. 2016 Apr 15;7:144
pubmed: 27148263
Blood. 2017 Apr 6;129(14):1927-1939
pubmed: 28209719
Clin Exp Immunol. 1985 Nov;62(2):278-87
pubmed: 3002684
Lancet Haematol. 2016 Mar;3(3):e119-27
pubmed: 26947200
J Exp Med. 2021 Dec 6;218(12):
pubmed: 34709350
J Clin Oncol. 2021 Feb 10;39(5):361-372
pubmed: 33434054

Auteurs

Norfarazieda Hassan (N)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Suzy Eldershaw (S)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Christine Stephens (C)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Francesca Kinsella (F)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Charles Craddock (C)

Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Ram Malladi (R)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Jianmin Zuo (J)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Paul Moss (P)

Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH